+---------+----++++------------+
| | |
+---------+----++++------------+
| | |
+---------+----++++------------+
| |
+---------+----++++------------+
|TR-1: |
|NOTIFICATION |
|OF MAJOR |
|INTEREST IN |
|SHARESi |
+---------+----++++------------+
| | |
+---------+----++++------------+
|1. Identity of |AstraZeneca |
|the issuer or |plc |
|the underlying | |
| issuer | |
| of existing | |
|shares to | |
|which voting | |
|rights are | |
| attached:ii | |
+---------+----++++------------+
|2 Reason for |
|the |
|notification |
|(please tick |
|the |
|appropriate |
|box or boxes): |
+---------+----++++------------+
|An | X |
|acquisition or | |
|disposal of | |
|voting rights | |
+---------+----++++------------+
|An | |
|acquisition or | |
|disposal of | |
|qualifying | |
|financial | |
|instruments | |
|which may | |
|result in | |
|the | |
|acquisition of | |
|shares already | |
|issued to | |
|which voting | |
|rights are | |
|attached | |
+---------+----++++------------+
|An | |
|acquisition or | |
|disposal of | |
|instruments | |
|with similar | |
|economic | |
|effect to | |
|qualifying | |
|financial | |
|instruments | |
+---------+----++++------------+
|An event | |
|changing the | |
|breakdown of | |
|voting rights | |
+---------+----++++------------+
|Other | | |
|(please | | |
|specify):| | |
+---------+----++++------------+
|3. Full name |The |
|of person(s) |Capital |
|subject to |Group |
|the |Companies, |
| notification|Inc. |
|obligation: | |
|iii | |
+---------+----++++------------+
|4. Full name |See |
|of |Schedule A |
|shareholder(s)| |
| (if | |
|different from| |
|3.):iv | |
+---------+----++++------------+
|5. Date of the|1 June |
|transaction |2015 |
|and date on | |
| which the | |
|threshold is | |
|crossed or | |
| reached: v| |
+---------+----++++------------+
|6. Date on |2 June |
|which issuer |2015 |
|notified: | |
+---------+----++++------------+
|7. |Below 3% |
|Threshold(s) | |
|that is/are | |
|crossed or | |
| reached: vi,| |
| vii | |
+---------+----++++------------+
| | |||| |
+---------+----++++------------+
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|8. Notified
|
|details:
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|A: Voting rights
|
|attached to shares
|
|viii, ix
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Class/type of |Situation |Resulting
|
| shares |previous |situation
|
| if possible| to the |after the
|
|using |triggering |triggering
|
| the ISIN CODE| transactio |transaction
|
| |n |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Number |Number |Number|Number of |% of |
| of | of | of |voting |voting |
| Shares | Voting |shares| rights |rights x |
| | Rights | | | |
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Direct |Direct |Indirect|Direct |Indirect |
| |xi |xii | | |
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Ordinary |31,704,772|31,704,772 | | | |
|2.4088% |
|Shares(ISIN: | | | | |30,437,552| |
|
|GB0009895292) | | | | | | |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|ADRs (ISIN: |7,433,161 |7,433,161 | | | |
|0.5884% |
|US0463531089) | | | | |7,435,104 | |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|B: Qualifying
|
|Financial
|
|Instruments
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Resulting situation
|
| after the
|
|triggering
|
|transaction
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Type of financial |Expiration |Exercise/ |Number of |% of
|
| instrument | date | Conversio |voting |voting
|
| |xiii |n Period | rights | right
|
| | |xiv |that may |s
|
| | | |be |
|
| | | | acquired |
|
| | | |if the |
|
| | | | instrumen |
|
| | | |t is |
|
| | | | exercised |
|
| | | |/ converted |
|
| | | |. |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
| | | | |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|C: Financial
|
|Instruments with
|
|similar economic
|
|effect to
|
|Qualifying
|
|Financial
|
|Instruments xv, xvi
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Resulting situation
|
| after the
|
|triggering
|
|transaction
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Type of financial|Exercise|Expiration|Exercise/ |Number of |% of
|
| instrument |price |date xvii | Conversio|voting |voting
|
| | | |n period |rights |rights
|
| | | |xviii |instrument |xix, xx
|
| | | | |refers to |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
| | | | |
|Nominal|Delta |
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
| | |
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Total (A+B+C)
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|Number of voting |Percentage
|
|rights |of
|
| |voting
|
| |rights
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
|37,872,656 |2.9972%
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
| | || | | || | | || |||| |
|
+---------------+-++-------+--------+-++-----+----+-------++----------++++-----+
------+
+-----------------------------+-----------------------+-------------------------
-+
|9. Chain of controlled undertakings through which the voting rights and/or
the|
| financial instruments are effectively held, if applicable: xxi
|
+-----------------------------+-----------------------+-------------------------
-+
|See Schedule A
|
+-----------------------------+-----------------------+-------------------------
-+
|
|
+-----------------------------+-----------------------+-------------------------
-+
|Proxy Voting:
|
+-----------------------------+-----------------------+-------------------------
-+
|10. Name of the proxy holder: |
|
+-----------------------------+-----------------------+-------------------------
-+
|11. Number of voting rights proxy holder will cease|
|
| to hold: |
|
+-----------------------------+-----------------------+-------------------------
-+
|12. Date on which proxy holder will cease to hold |
|
| voting rights: |
|
+-----------------------------+-----------------------+-------------------------
-+
|
|
+-----------------------------+-----------------------+-------------------------
-+
| 13. Additional information:|
|
| |
|
+-----------------------------+-----------------------+-------------------------
-+
|14. Contact name: |
|
+-----------------------------+-----------------------+-------------------------
-+
|15. Contact telephone number:|
|
+-----------------------------+-----------------------+-------------------------
-+
| | |
|
+-----------------------------+-----------------------+-------------------------
-+
Schedule A
As of 1 June 2015
AstraZeneca PLC
Number of Shares Percent of Outstanding
The Capital Group 37,872,656 2.997%
Companies, Inc. (“CG”)
holdings
Holdings by CG
Management Companies and
Funds:
Capital Guardian Trust 5,512,014 0.436%
Company
Capital International 165,100 0.013%
Limited
Capital International 154,992 0.012%
Sàrl
Capital International, 72,900 0.006%
Inc.
Capital Research and 31,967,650 2.530%
Management Company
Holding(s) in Company
| Quelle: AstraZeneca PLC
Anhänge
